Plexus Brachialis Block. Better to do by Start Than by End of Surgery?

The aim of the study is to find out if the timing of brachial plexus block, before or after surgery, has an impact of the extent of acute postoperative surgical pain or the incidence and severity of long-lasting (chronic) pain after surgery.

This is a prospective, randomized, double blind study in patients with radial fractures undergoing surgery with volar plate. The patients will be followed up for 6 months after surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Oslo Universitetssykehus, Ullevaal, dept of anaesthesiology, legevakten

Oslo, 0540, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Radial fracture
ASA 1 and 2
Able to communicate in norwegian
Suitable for surgery in general anaesthesia and brachial plexus block

Exclusion criteria

Pregnancy
Chronic pain
BMI over 35

Treatment and study plan

Plexus brachialis block

Procedure

Other names: LSIB. Ropivacain 7,5 mg/ml, 0,5 ml/kg

Primary outcomes

Pain

Time frame: postoperative to 6 months

NAS

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Important dates

Study start: 2012
Primary completion: 2015
Study completion: 2016
First posted: Dec 4, 2012
Registry last updated: Apr 6, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed